Merck, D048-100MG, MPP+ iodide

General description
1-Methyl-4-phenylpyridinium (MPP+) acts as a selective ERα antagonist.induces neurotoxicity by inhibiting mitochondrial redox functions in the striatal synaptosomes. It is a potential neurotoxin and induces Parkinson′s disease in animal models. It mediates apoptosis by the generation of reactive oxygen species in cerebellar granule neurons and neuroblastoma cells. MPP+ modulates the distribution of dopamine. It elicits neurotoxicity by activating neuronal nitric oxide synthase (nNOS), resulting in excess nitric oxide.
Application
MPP+ iodide has been used:
to induce oxidative stress in zebrafish embryos
for the inhibition of glutamate uptake in mitochondria of astrocytes
in testing cell viability using MTT (3 (4,5-dimethylthiazol)-2-yl-2,5-diphenyltetrazolium bromide) in microglia (BV2) cells

Biochem/physiol Actions
Active metabolite of dopaminergic neurotoxin MPTP
MPP+ iodide is an active metabolite of dopaminergic neurotoxin MPTP.
Preparation Note
Solutions should be freshly prepared.
Other Notes
2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research
Disclaimer
Photosensitive.